In addition to the Placement, Birimian intends to undertake a non-renounceable 1:20entitlements issue at an issue price of $0.17. Assuming the shares from the Placementannounced today are issued, the 1:20 ratio would imply that the entitlement issue wouldconsist of an offer of approximately 13,428,035 new shares (Entitlements Issue). Theprospectus for the Entitlements Issue will be lodged late January 2019 in order to giveshareholders maximum opportunity to participate. Funds raised pursuant to the Anticipated Entitlements Issue will be also be directed towardsthe Company’s wholly owned Project, consistent with the Placement.
- Forums
- ASX - By Stock
- Ann: Birimian Completes Business Review and Capital Raising
In addition to the Placement, Birimian intends to undertake a...
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online